Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$30.43 - $53.43 $8.86 Million - $15.6 Million
-291,222 Reduced 55.83%
230,410 $9.28 Million
Q1 2024

May 15, 2024

SELL
$22.09 - $35.41 $9.52 Million - $15.3 Million
-430,930 Reduced 45.24%
521,632 $18.5 Million
Q4 2023

Feb 14, 2024

SELL
$14.28 - $31.03 $1.36 Million - $2.96 Million
-95,401 Reduced 9.1%
952,562 $28.2 Million
Q3 2023

Nov 14, 2023

BUY
$19.33 - $36.22 $3.3 Million - $6.19 Million
170,932 Added 19.49%
1,047,963 $21.8 Million
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $9.49 Million - $16.7 Million
392,407 Added 80.97%
877,031 $21.5 Million
Q1 2023

May 15, 2023

BUY
$35.86 - $46.5 $15.6 Million - $20.2 Million
434,770 Added 872.09%
484,624 $19.7 Million
Q4 2022

Feb 14, 2023

SELL
$35.49 - $56.15 $1.13 Million - $1.79 Million
-31,905 Reduced 39.02%
49,854 $2.24 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $897,342 - $1.41 Million
20,506 Added 33.48%
81,759 $3.91 Million
Q2 2022

Aug 15, 2022

BUY
$53.22 - $123.09 $3.26 Million - $7.54 Million
61,253 New
61,253 $3.63 Million
Q1 2022

May 16, 2022

SELL
$101.89 - $150.09 $2.23 Million - $3.28 Million
-21,839 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $2.58 Million - $3.35 Million
21,839 New
21,839 $3.29 Million
Q2 2021

Aug 16, 2021

SELL
$77.0 - $100.19 $2.42 Million - $3.16 Million
-31,491 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$81.28 - $104.34 $2.56 Million - $3.29 Million
31,491 New
31,491 $2.78 Million
Q2 2019

Aug 14, 2019

SELL
$54.41 - $71.7 $1.16 Million - $1.53 Million
-21,349 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$32.25 - $73.56 $688,505 - $1.57 Million
21,349 New
21,349 $1.36 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.